AI assistant
Sending…
REVVITY, INC. — Director's Dealing 2012
Feb 6, 2012
30616_dirs_2012-02-06_0e3d8097-a9ff-449a-86e1-c1bd548fd83c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PERKINELMER INC (PKI)
CIK: 0000031791
Period of Report: 2012-02-01
Reporting Person: Corbett James (S V P, President Diagnostics)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 13537 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| NQ Stock Option (Right to Buy) | $12.95 | 2016-02-03 | Common Stock (10000) | Direct | |
| NQ Stock Option (Right to Buy) | $21.01 | 2017-02-09 | Common Stock (3899) | Direct | |
| NQ Stock Option (Right to Buy) | $19.47 | 2017-07-15 | Common Stock (23786) | Direct | |
| NQ Stock Option (Right to Buy) | $26.58 | 2018-02-08 | Common Stock (19770) | Direct |
Footnotes
F1: This option vests in three equal annual installments, beginning one year from the grant date, and may be exercised for seven years from the grant date.
More from REVVITY, INC.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 16
Proxy Solicitation & Information Statement
2026
Mar 16
Proxy Solicitation & Information Statement
2026
Mar 16
Regulatory Filings
2026
Mar 6
Director's Dealing
2026
Feb 26